Product Information
MIDAZOLAM HCL 2 MG/2 ML VIAL is a generic product labeled by Civica, Inc., priced at $0.2334 per ML under NDC 72572043025. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on Jun 20, 2000. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Civica, Inc.NDC
72572043025
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075243FDA Approved
6/20/2000
TE Code
AP
On Market Since
12/10/2019
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has been published 107 times since Sep 18, 2024, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2334 per ML |
|---|---|
| All-time high | $0.2408 (Mar 11, 2026) |
| All-time low | $0.1862 (Sep 18, 2024) |
| 52-week high | $0.2408 |
| 52-week low | $0.2269 |
| Median price | $0.2269 |
| Average price | $0.2184 |
| Largest weekly change | +6.2% (Nov 20, 2024) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Civica, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Midazolam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 2 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 2 MG/2 ML VIAL, manufactured by Civica, Inc., is $0.2334 per ML (NDC 72572043025), effective Sep 30, 2026.
How has the price of MIDAZOLAM HCL 2 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has risen 25.4%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 2 MG/2 ML VIAL?
Since Sep 18, 2024, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has ranged from a low of $0.1862 (Sep 18, 2024) to a high of $0.2408 (Mar 11, 2026), with a median of $0.2269 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 2 MG/2 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MIDAZOLAM HCL 2 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures MIDAZOLAM HCL 2 MG/2 ML VIAL?
MIDAZOLAM HCL 2 MG/2 ML VIAL (NDC 72572043025) is labeled by Civica, Inc., and CMS classifies it as a generic product.